With expert speakers coming in from around the country for Cannabis Science Conference Fall, we thought it was a great opportunity to introduce some of them and get a sneak peek into their presentations. Here, we meet Jini Glaros, Chief Scientific Officer at Modern Canna Labs.
Cannabis Science Conference (CSC) Fall will be taking place in Providence, Rhode Island September 20-22nd. CSC Fall features several exciting tracks: analytical science, cultivation, medical cannabis, and psychedelics. With expert speakers coming in from around the country, we thought it was a great opportunity to introduce some of them and get a sneak peek into their presentations. Jini Glaros, Chief Scientific Officer at Modern Canna Labs in Lakeland, Florida, will be presenting in an analytical-focused general session on Friday, September 22nd. Her talk is titled “Sample Preparation, Compound Error, and Potency Inflation.” Here, Glaros shares how she got her start in cannabis testing as well as a little preview of what to expect from her exciting talk!
Can you tell us about your background and how you got involved with cannabis testing?
Jini Glaros: Of course. So, if you had asked me 10 years ago if I would be doing cannabis testing like probably a lot of people in the industry, I would have said, ‘No, there's no way.’ My original plan was I wanted to get a medical degree and be a doctor. I worked in a lab during my undergraduate education and fell in love with it. I ended up taking a gap year after graduation, which was when I worked at the National Institute on Aging in Baltimore, Maryland. During that time, I realized that it was lab life for me; I wanted to be in the lab. There was no doubt about it. So, I thought maybe I'll pursue my MD and PhD. I'll still get to be in a lab and still get to be a doctor—kind of the best of both worlds. Of course, sometimes life happens and that didn't work out, but everything happens for a reason. I ended up working at the University of Florida for a while in one of their labs, before moving back to my hometown of Lakeland, Florida, which is where the Modern Canna Labs’ headquarters is located and where I'm working currently. This opportunity really just fell into my lap, and I couldn't be happier about my role and thrilled that I was given such an opportunity. I got in the industry when things were very fresh and new in Florida. I started working for Modern Canna back in 2017, so I've been with them for quite some time now, and really have been able to watch the company grow.
What are you most looking forward to at the Cannabis Science Conference this fall?
Glaros: I think the networking opportunities, as well as the presentations relating to all aspects of cannabis. As a scientist, of course, the analytical track is very exciting to me and I'm looking forward to seeing all of those presentations, but I'm also interested in the presentations that relate to medical cannabis, cultivation, and psychedelics because it will allow me to get a little bit out of my comfort zone and to learn something new—something that maybe I did not know about. Some of the best collaborations can come from those sort of things because you can see a cultivator present and you're like, ‘Oh, wait, we could partner on something and you could cultivate and I could do some science.’ It's opportunities like that which come from conferences where you're bringing all aspects of the industry together.
Can you give us a little preview of what you'll be discussing in your talk?
Glaros: Potency is a highly scrutinized analysis, whether that be from cultivators, producers, or even consumers, right? You hear all the time that consumers want the most “fire” weed, or they want cannabis with the highest THC. It's great that they want high THC flower, but that's not the only thing that matters. When it comes to high THC flower, by the industry pushing for higher and higher potencies, it's led some laboratories to maliciously manipulate their data. However, the reality is that, in most cases, I really don't think that's the intention of all laboratories. I think, ultimately, that some of these labs just don't have the tools and the techniques to know when they're doing something that could be leading to potency inflation or could be leading to results that are skewed in one way or another. So, the goal of my talk is to uncover some of those things that lead to compound error, which may in turn lead to potency inflation. We're going to dive into sampling bias, sample weighing, sample extraction, sample dilutions—the whole nine yards—and how each step of that process impacts the final result. I’ll also discuss how laboratories can improve their processes and what cultivators, producers, and regulators can look for when they're looking to a lab to produce accurate data.
Stay tuned for more with Jini Glaros with our live video conference coverage taking place September 21-22, 2023 or join us in person to hear Jini’s presentation and countless others at the Cannabis Science Conference Fall in Providence, RI. Register today with code EARLYBIRD to save 30%: https://bit.ly/3pIBuJp!
Inside the University of Maryland School of Pharmacy’s Graduate Program in Medical Cannabis
September 16th 2024Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
Studying the Evolution of Cannabis Education: Insights from Stockton University’s Course Instructors
September 13th 2024A leader in cannabis education in New Jersey, Stockton University offers a wide variety of courses to prepare its students to not only succeed in an ever-growing industry, but to also understand its complex history and shape its evolving future. Started six years ago, its Cannabis Studies Program continues its commitment to providing innovative and practical instruction to its students. Two influential figures in this space are Robert Mejia, Teaching Specialist in the Cannabis Studies Program, and Angela Speakman, Instructor in the Cannabis Studies Program. Here, they highlight the program’s practical approach to cannabis education, celebrate the success stories of graduates, discuss the National Cannabis Curriculum Convening, and address challenges in cannabis education and its role in the future.
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
Insights on Cannabis Testing Challenges and Industry Standards: An Interview with Douglas Duncan
August 9th 2024In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.
Patients on the Front Line: Nikki Lawley’s Insights on Medical Cannabis Today
June 25th 2024In the ongoing dialogue surrounding cannabis, the testimonials of medical cannabis patients stand as crucial reminders of its impacts and benefits in the industry. For a deep dive into this topic, Cannabis Science and Technology sat down with Nikki Lawley, founder of Nikki and the Plant, LLC, for her take on the challenges patients face today in the midst of discussions of industry developments such as the rescheduling of cannabis. A traumatic brain injury survivor, Lawley now actively supports medical cannabis access and engages diverse audiences through her journey as a pediatric nurse-turned-patient-and-advocate. Here, she explains the importance of educating people about cannabis, the need for patient perspective in cannabis policy decisions, and the benefits of empathetic approaches to medical cannabis use.
Foundations for the Future: The University of Rhode Island’s Cannabis Education Program
March 5th 2024The continued expansion of the cannabis industry, particularly in the new recreational market in Rhode Island, is simultaneously increasing the opportunities for professions as well. One advantage here is education; formal training from experts provides an edge for those looking to lead and innovate in their field. In response to this need, the University of Rhode Island (URI) offers an Undergraduate Certificate in Cannabis Studies, a minor in cannabis studies, an upcoming Graduate Certificate in Cannabis Sciences, and more in order to evolve the way students learn and are prepared for the wide-ranging opportunities in the cannabis industry. In this interview, Program Director Stephanie Forschner-Dancause, PhD, shares insights into the curriculum of URI’s cannabis courses as they prepare students to ensure the industry's future is credible and grounded in evidence-based practices.